These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2523643)

  • 21. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of calcium-channel blockers in pregnancy.
    Lewis R; Sibai BM
    New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of calcium antagonists in the treatment of arterial hypertension].
    Chazova IE
    Ter Arkh; 2001; 73(8):80-3. PubMed ID: 11599278
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium antagonists should continue to be used for first-line treatment of hypertension.
    Epstein M
    Arch Intern Med; 1995 Nov; 155(20):2150-6. PubMed ID: 7487236
    [No Abstract]   [Full Text] [Related]  

  • 25. Isradipine in the treatment of hypertension: a clinical profile.
    Vidt DG
    Cleve Clin J Med; 1990; 57(8):677-84. PubMed ID: 2147874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arterial hypertension in the elderly: a therapeutic problem].
    Rico L; Velasco J
    Rev Clin Esp; 1989 Nov; 185(8):55-6 p.. PubMed ID: 2696004
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mibefradil--a T-type calcium channel blocker].
    Roguin A; Edoute Y
    Harefuah; 1999 Jan; 136(2):167-9. PubMed ID: 10914190
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F; Kushiro T
    Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension in patients with diabetes mellitus.
    Agarwal R
    Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
    Pirrelli A; Vulpis V
    Cardiologia; 1998 Apr; 43(4):357-64. PubMed ID: 9659793
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of the calcium antagonist isradipine.
    Rüegg UT; Hof RP
    Drugs; 1990; 40 Suppl 2():3-9. PubMed ID: 2150637
    [No Abstract]   [Full Text] [Related]  

  • 32. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Fitton A; Benfield P
    Drugs; 1990 Jul; 40(1):31-74. PubMed ID: 2143980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral agents for acute severe hypertension in children with minimal or no symptoms.
    Hijazzi S; Moon K; Larkins NG
    J Paediatr Child Health; 2022 Nov; 58(11):1935-1941. PubMed ID: 36129141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isradipine in hypertension. Proceedings of an international symposium. Athens, Greece, October 21, 1988.
    Am J Med; 1989 Apr; 86(4A):1-146. PubMed ID: 2523643
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 36. From channels to cats: an overview of isradipine pharmacology.
    Rüegg UT; Hof RP
    Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review.
    Dahlöf B
    Cor Vasa; 1990; 32(2 Suppl 1):23-34. PubMed ID: 2143458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.